What Henry Meds advertises for compounded tirzepatide, and what to verify before you enroll. Independent — we are not paid by Henry Meds.
| Pricing model | Telehealth, cash-pay |
|---|---|
| Starter price | ~$199–$299/mo |
| Higher-dose price | May vary by dose |
| Annualized cost (est.) | ~$2,388–$3,588 (estimated) |
| Dose-based increase | Verify |
| Shipping | Verify |
| Labs | Verify |
| Provider visits | Usually included |
Verify. Because the price can rise as you titrate up, the figure that matters for your budget is the maintenance-dose price, not the starter price. See why prices increase by dose.
Confirm the dispensing pharmacy, its 503A/503B status, and CoA availability directly.
Because compounded tirzepatide is not FDA-approved as a finished product, the pharmacy is the key quality signal. See what pharmacy fills compounded tirzepatide and 503A vs 503B.
Broad telehealth availability; confirm your state directly.
Confirm whether shipping is included or billed separately.
Cancellation: Confirm cancellation terms directly.
Refunds: Confirm refund policy directly.
Pricing and policy details were checked July 2026 against publicly available information. Sources:
Spot an error or out-of-date figure? Submit an update or a correction — we verify before changing pages.
As of July 2026, Henry Meds's advertised pricing is ~$199–$299/mo, with higher-dose pricing: May vary by dose. Verify current figures directly; compounded tirzepatide is not FDA-approved.
Dose-based increase: Verify. Confirm the price at your expected maintenance dose before enrolling.
Confirm the dispensing pharmacy, its 503A/503B status, and CoA availability directly.
Broad telehealth availability; confirm your state directly.